In the battle to reduce childhood overweight and obesity, several in-home factors have been identified as reducing those risks – participation of children in regular family dinners, getting enough sleep and less time watching television or other "screen time." A new study appearing in JAMA Pediatrics describes how a home-based program that helped at-risk families improve household routines was able to slow weight gain in a group of young children.
Culture
In one of the first studies of its kind, a joint UCLA/RAND Corporation study addressed the prevalence and cost of critical care therapies provided in intensive care units (ICU) that were perceived by physicians as "futile."
Reported in the Sept. 9 online issue of JAMA Internal Medicine, researchers found that the majority of patients received appropriate care, but 11 percent of patients received treatments during their ICU course that their physicians perceived to be futile. The study took place at a single health care system.
Critical care treatment for patients that was perceived to be futile was common and cost an estimated at $2.6 million at one academic medical center during a three-month period, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
Undervaccination with the diptheria, tetanus toxoids and acelluar pertussis (DTaP) vaccine appears to be associated with an increased risk of pertussis (whooping cough) in children 3 to 36 months of age, according to a study by Jason M. Glanz, Ph.D., of the Institute for Health Research at Kaiser Permanente Colorado, Denver.
"Undervaccination is an increasing trend that potentially places children and their communities at an increased risk for serious infectious disease," according to the study.
TORONTO, Sept. 9, 2013 – Men were more likely to develop a physical illness than women during a 10-year period studied by researchers at St. Michael's Hospital.
Monday, September 9, 2013, Cleveland: Most patients who report statin intolerance, including muscle aches and other side effects from the cholesterol-lowering drugs, can actually tolerate drugs from this class on subsequent trials, according to research from Cleveland Clinic recently released online and forthcoming in the September issue of the American Heart Journal. The study is the largest ever to examine the effects of re-challenging statin-intolerant patients.
INDIANAPOLIS, Sept. 9, 2013 — The first study under realistic field conditions has found reassuringly low levels of pharmaceuticals and personal care products (PPCPs) in crops irrigated with recycled sewage water, scientists reported at the 246th National Meeting & Exposition of the American Chemical Society.
INDIANAPOLIS, Sept. 9, 2013 — Even though the Great Recession officially ended more than three years ago in the U.S., lingering effects continue to impact careers for thousands of scientists. Advancing those careers for chemists and other scientists is the topic today of a special presidential symposium at the 246th National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society.
HEIDELBERG -- A preclinical study led by researchers in the United States has found that a new oral drug shows early promise for the treatment of muscular dystrophy. The results, which are published today in EMBO Molecular Medicine, show that VBP15 decreases inflammation in mice with symptoms similar to those found in patients with Duchenne muscular dystrophy. The authors found that the drug protects and strengthens muscle without the harsh side effects linked to current treatments with glucocorticoids such as prednisone.
Barcelona, Spain: People with severe asthma, who are often described as 'steroid-dependent', are actually less likely to respond to the treatment they depend on, when compared to people with mild asthma.
The study, presented at the European Respiratory Society (ERS) Annual Congress in Barcelona today (9 September 2013), represents the first analysis of a cohort of patients from an unparalleled research project that will collect over 3 million samples from 300 children and 700 adults with severe and non-severe asthma, and without asthma.
New research reveals that large labor wards—those handling 3,000 to 3,999 deliveries annually—have better overall approval rates compared to small, intermediate or very large obstetric units. The study, appearing in Acta Obstetricia et Gynecologica Scandinavica, a journal published by Wiley on behalf of the Nordic Federation of Societies of Obstetrics and Gynecology, suggests that greater access to in-house obstetricians and auxiliary specialists contributes to the lower obstetric injury claims from patients at large labor wards in Denmark.
Music has an uncanny way of bringing us back to a specific point in time, and each generation seems to have its own opinions about which tunes will live on as classics. New research suggests that young adults today are fond of and have an emotional connection to the music that was popular for their parents' generation.
INDIANAPOLIS, Sept. 8, 2013 — How many breakthrough new drugs never reach patients because tests in clinical trials suggested a high risk of liver damage when the drug actually was quite safe?
Many cancer therapies function by activating proteins like Caspase-3 (CASP3) that promote cell death. Several forms of cancer develop resistance to these drugs by down regulating CASP3 through an unknown mechanism.
In the absence of CASP3, tumor cells produce another cell death promoting protein CASP7, but it is rendered inactive by the X-linked inhibitor of apoptosis protein (XIAP). In the Journal of Clinical Investigation, Po-Huang Liang and colleagues at Academia Sinica identify a compound (I-Lys) that disrupts the interaction between CASP7 and XIAP.
SAN FRANSISCO, CA – Five additional studies of note are among those that will be presented at the 2013 Breast Cancer Symposium, taking place September 7-9, 2013 at the San Francisco Marriott Marquis in San Francisco, California. Two studies examine cognitive function in women who undergo treatment for early-stage breast cancer; a third evaluates impact of tumor genotyping on clinical trial enrollment; and the final two evaluate the outcomes of different treatment approaches.
Saturday, September 7 Presentations